
### [MONDO:0001340](http://purl.obolibrary.org/obo/MONDO_0001340)
**Label:** heart cancer

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0017833](http://purl.obolibrary.org/obo/MONDO_0017833) (primary hypereosinophilic syndrome), [MONDO:0015673](http://purl.obolibrary.org/obo/MONDO_0015673) (rare cardiac tumor), [MONDO:0013671](http://purl.obolibrary.org/obo/MONDO_0013671) (hydatidiform mole, recurrent, 2), [MONDO:0003805](http://purl.obolibrary.org/obo/MONDO_0003805) (malignant pericardial mesothelioma), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0019494](http://purl.obolibrary.org/obo/MONDO_0019494) (primary pediatric heart tumor), [MONDO:0019493](http://purl.obolibrary.org/obo/MONDO_0019493) (primary adult heart tumor), [MONDO:0003743](http://purl.obolibrary.org/obo/MONDO_0003743) (heart malignant hemangiopericytoma), [MONDO:0003687](http://purl.obolibrary.org/obo/MONDO_0003687) (endocardium cancer), [MONDO:0003742](http://purl.obolibrary.org/obo/MONDO_0003742) (heart fibrosarcoma), [MONDO:0003104](http://purl.obolibrary.org/obo/MONDO_0003104) (epicardium cancer), [MONDO:0001322](http://purl.obolibrary.org/obo/MONDO_0001322) (pericardium cancer), [MONDO:0004752](http://purl.obolibrary.org/obo/MONDO_0004752) (neurofibroma of the heart), [MONDO:0009719](http://purl.obolibrary.org/obo/MONDO_0009719) (familial atrial myxoma), [MONDO:0017817](http://purl.obolibrary.org/obo/MONDO_0017817) (primary localized amyloidosis), [MONDO:0017816](http://purl.obolibrary.org/obo/MONDO_0017816) (primary systemic amyloidosis), [MONDO:0011895](http://purl.obolibrary.org/obo/MONDO_0011895) (idiopathic hypereosinophilic syndrome), [MONDO:0017835](http://purl.obolibrary.org/obo/MONDO_0017835) (lymphocytic hypereosinophilic syndrome), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), [MONDO:0017129](http://purl.obolibrary.org/obo/MONDO_0017129) (genetic cardiac tumor), [MONDO:0003917](http://purl.obolibrary.org/obo/MONDO_0003917) (heart lymphoma), [MONDO:0019122](http://purl.obolibrary.org/obo/MONDO_0019122) (idiopathic acute eosinophilic pneumonia), [MONDO:0004803](http://purl.obolibrary.org/obo/MONDO_0004803) (disseminated eosinophilic collagen disease), [MONDO:0004749](http://purl.obolibrary.org/obo/MONDO_0004749) (myocardium cancer), [MONDO:0004802](http://purl.obolibrary.org/obo/MONDO_0004802) (pulmonary eosinophilia), [MONDO:0001991](http://purl.obolibrary.org/obo/MONDO_0001991) (malignant cardiac germ cell tumor), [MONDO:0004941](http://purl.obolibrary.org/obo/MONDO_0004941) (eosinophilia-myalgia syndrome), [MONDO:0001990](http://purl.obolibrary.org/obo/MONDO_0001990) (malignant cardiac peripheral nerve sheath neoplasm), [MONDO:0003354](http://purl.obolibrary.org/obo/MONDO_0003354) (heart sarcoma), [MONDO:0003353](http://purl.obolibrary.org/obo/MONDO_0003353) (heart leiomyosarcoma), [MONDO:0006123](http://purl.obolibrary.org/obo/MONDO_0006123) (cardiac rhabdomyoma (disease)), 

**Mapped go classes:** [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye), [GO:0045762](http://purl.obolibrary.org/obo/GO_0045762) (positive regulation of adenylate cyclase activity), [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development), [GO:0002244](http://purl.obolibrary.org/obo/GO_0002244) (hematopoietic progenitor cell differentiation), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0005902](http://purl.obolibrary.org/obo/GO_0005902) (microvillus), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0061047](http://purl.obolibrary.org/obo/GO_0061047) (positive regulation of branching involved in lung morphogenesis), [GO:0035790](http://purl.obolibrary.org/obo/GO_0035790) (platelet-derived growth factor receptor-alpha signaling pathway), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0001553](http://purl.obolibrary.org/obo/GO_0001553) (luteinization), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0030539](http://purl.obolibrary.org/obo/GO_0030539) (male genitalia development), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0010544](http://purl.obolibrary.org/obo/GO_0010544) (negative regulation of platelet activation), [GO:0031226](http://purl.obolibrary.org/obo/GO_0031226) (intrinsic component of plasma membrane), [GO:0034614](http://purl.obolibrary.org/obo/GO_0034614) (cellular response to reactive oxygen species), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0008603](http://purl.obolibrary.org/obo/GO_0008603) (cAMP-dependent protein kinase regulator activity), [GO:0038091](http://purl.obolibrary.org/obo/GO_0038091) (positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway), [GO:0001772](http://purl.obolibrary.org/obo/GO_0001772) (immunological synapse), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0006935](http://purl.obolibrary.org/obo/GO_0006935) (chemotaxis), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0008210](http://purl.obolibrary.org/obo/GO_0008210) (estrogen metabolic process), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0038085](http://purl.obolibrary.org/obo/GO_0038085) (vascular endothelial growth factor binding), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001932](http://purl.obolibrary.org/obo/GO_0001932) (regulation of protein phosphorylation), [GO:0030198](http://purl.obolibrary.org/obo/GO_0030198) (extracellular matrix organization), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0023019](http://purl.obolibrary.org/obo/GO_0023019) (signal transduction involved in regulation of gene expression), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0048557](http://purl.obolibrary.org/obo/GO_0048557) (embryonic digestive tract morphogenesis), [GO:0005952](http://purl.obolibrary.org/obo/GO_0005952) (cAMP-dependent protein kinase complex), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0004862](http://purl.obolibrary.org/obo/GO_0004862) (cAMP-dependent protein kinase inhibitor activity), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0042060](http://purl.obolibrary.org/obo/GO_0042060) (wound healing), [GO:0055003](http://purl.obolibrary.org/obo/GO_0055003) (cardiac myofibril assembly), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0070527](http://purl.obolibrary.org/obo/GO_0070527) (platelet aggregation), [GO:0045859](http://purl.obolibrary.org/obo/GO_0045859) (regulation of protein kinase activity), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0060437](http://purl.obolibrary.org/obo/GO_0060437) (lung growth), [GO:0003261](http://purl.obolibrary.org/obo/GO_0003261) (cardiac muscle progenitor cell migration to the midline involved in heart field formation), [GO:0043552](http://purl.obolibrary.org/obo/GO_0043552) (positive regulation of phosphatidylinositol 3-kinase activity), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0010863](http://purl.obolibrary.org/obo/GO_0010863) (positive regulation of phospholipase C activity), [GO:0050920](http://purl.obolibrary.org/obo/GO_0050920) (regulation of chemotaxis), [GO:0033327](http://purl.obolibrary.org/obo/GO_0033327) (Leydig cell differentiation), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0045740](http://purl.obolibrary.org/obo/GO_0045740) (positive regulation of DNA replication), [GO:0042475](http://purl.obolibrary.org/obo/GO_0042475) (odontogenesis of dentin-containing tooth), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0097271](http://purl.obolibrary.org/obo/GO_0097271) (protein localization to bud neck), [GO:0005930](http://purl.obolibrary.org/obo/GO_0005930) (axoneme), [GO:2000739](http://purl.obolibrary.org/obo/GO_2000739) (regulation of mesenchymal stem cell differentiation), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0071230](http://purl.obolibrary.org/obo/GO_0071230) (cellular response to amino acid stimulus), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0005021](http://purl.obolibrary.org/obo/GO_0005021) (vascular endothelial growth factor-activated receptor activity), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0007204](http://purl.obolibrary.org/obo/GO_0007204) (positive regulation of cytosolic calcium ion concentration), [GO:0005018](http://purl.obolibrary.org/obo/GO_0005018) (platelet-derived growth factor alpha-receptor activity), [GO:0072277](http://purl.obolibrary.org/obo/GO_0072277) (metanephric glomerular capillary formation), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030552](http://purl.obolibrary.org/obo/GO_0030552) (cAMP binding), [GO:0071901](http://purl.obolibrary.org/obo/GO_0071901) (negative regulation of protein serine/threonine kinase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), 

**Class expressions from DL-Learner:**

- Thing 53.67%
- [GO:0070527](http://purl.obolibrary.org/obo/GO_0070527) (platelet aggregation) 51.52%
- [GO:0060437](http://purl.obolibrary.org/obo/GO_0060437) (lung growth) 51.52%
- [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding) 51.52%
- [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity) 51.52%
- [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding) 51.52%
- [GO:0038085](http://purl.obolibrary.org/obo/GO_0038085) (vascular endothelial growth factor binding) 51.52%
- [GO:0033327](http://purl.obolibrary.org/obo/GO_0033327) (Leydig cell differentiation) 51.52%
- [GO:0030552](http://purl.obolibrary.org/obo/GO_0030552) (cAMP binding) 51.52%
- [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface) 51.52%
- [GO:0008603](http://purl.obolibrary.org/obo/GO_0008603) (cAMP-dependent protein kinase regulator activity) 51.52%
- [GO:0005930](http://purl.obolibrary.org/obo/GO_0005930) (axoneme) 51.52%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 51.52%
- [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding) 51.52%
- [GO:0005018](http://purl.obolibrary.org/obo/GO_0005018) (platelet-derived growth factor alpha-receptor activity) 51.52%


